AllianzIM U.S. Large Cap Buffer20 Dec ETF (DECW) is an exchange-traded fund that seeks to provide investors with share price returns tracking the SPDR S&P 500 ETF Trust (SPY) up to a specified upside cap at the end of a defined one-year outcome period, while offering a buffer against the first 20% of losses in the underlying ETF before fees and expenses. The fund achieves these buffered outcomes through investments substantially in FLEXible EXchange (FLEX) options, which are customized equity options cleared by the Options Clearing Corporation, enabling precise cap and buffer levels that reset annually from December 1 to November 30; outcomes apply only if shares are held for the full period, with caps and buffers adjusted post-fees. Launched on November 30, 2022, DECW forms part of Allianz Investment Management LLC's (AllianzIM) broader suite of buffered outcome ETFs, including monthly 12-month Buffer20 and Buffer10 series (e.g., JANW, FEBW, DECT), six-month Buffer10 series (e.g., SIXJ, SIXD), and quarterly Buffer15 products like QBSF, all linked to S&P 500 performance and targeted at U.S. investors seeking defined-risk equity exposure.
AllianzIM, the fund's adviser and a registered investment adviser headquartered in Minneapolis, Minnesota as a wholly owned subsidiary of Allianz Life Insurance Company of North America, specializes in structured outcome ETFs within the asset management segment, with operations focused on the U.S. market. In January 2025, AllianzIM introduced a new suite of Buffer Allocation ETFs, featuring laddered portfolios of underlying buffered ETFs that reset monthly to provide diversified downside protection (10% or 20% buffers) and capital appreciation potential, reducing cap timing risk across varying market conditions. This expansion complements DECW's ongoing annual resets, such as the current outcome period from December 1, 2024, to November 30, 2025, amid steady assets under management and a 0.74% expense ratio. No major acquisitions, funding rounds, or reorganizations specific to DECW or AllianzIM were reported in the last 1-2 years.